PRIDALEZE Trademark

Trademark Overview

On Wednesday, December 19, 2012, a trademark application was filed for PRIDALEZE with the United States Patent and Trademark Office. The USPTO has given the PRIDALEZE trademark a serial number of 79124162. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, December 19, 2022. This trademark is owned by AstraZeneca AB. The PRIDALEZE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
pridaleze

General Information

Serial Number79124162
Word MarkPRIDALEZE
Filing DateWednesday, December 19, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, December 19, 2022
Registration Number4472996
Registration DateTuesday, January 28, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSE

Trademark Events

Event DateEvent Description
Wednesday, July 19, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Wednesday, July 19, 2023DEATH OF INTERNATIONAL REGISTRATION
Saturday, February 26, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, January 26, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, January 26, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Friday, February 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 28, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, July 4, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, June 13, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 13, 2014FINAL DISPOSITION PROCESSED
Monday, April 28, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 28, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, November 12, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2013PUBLISHED FOR OPPOSITION
Wednesday, October 23, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 9, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 9, 2013ASSIGNED TO LIE
Thursday, September 26, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 11, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 11, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 11, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 16, 2013REFUSAL PROCESSED BY IB
Tuesday, March 26, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 26, 2013REFUSAL PROCESSED BY MPU
Monday, March 25, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, March 24, 2013NON-FINAL ACTION WRITTEN
Friday, March 22, 2013ASSIGNED TO EXAMINER
Friday, February 1, 2013APPLICATION FILING RECEIPT MAILED
Monday, January 28, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 24, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

pridaleze diseases disorders substances preparations pharmaceutical nervous system inflammation infection gastrointestinal